| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/24/2007 | US7247645 Dihydropyridine derivatives |
| 07/24/2007 | US7247640 Comprises as an active ingredient a sulphostin-related compound such as 3(S)-amino-1-((S)-amino(sulfoamino)-phosphinyl)-2-piperidone |
| 07/24/2007 | US7247630 Nitrogen compounds such as 3-(5-hydroxyhexyl)-1-methyl-1H-imidazo(2,1-f)purine-2,4(3H,6H)-dione, used for prophylaxis of diseases associated with cytokine intracellular signal transduction |
| 07/24/2007 | US7247622 Antibiotic; beta-lactamase inhibitor; therapy for infection |
| 07/24/2007 | US7247610 Suppression tumor growth |
| 07/24/2007 | US7247472 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 07/24/2007 | US7247446 PRO34128 nucleic acids |
| 07/24/2007 | US7247445 2-O sulfatase compositions and methods of hydrolyzing therewith |
| 07/24/2007 | US7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 07/24/2007 | CA2317834C Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnf.alpha. levels |
| 07/24/2007 | CA2246429C Erbb3 antibodies |
| 07/24/2007 | CA2238274C Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 07/24/2007 | CA2230350C Combination preparation for use in dementia |
| 07/24/2007 | CA2172777C Use of a cgrp antagonist for the treatment of neurogenic skin redness; composition thus produced |
| 07/24/2007 | CA2121798C Novel cytokine |
| 07/24/2007 | CA2097185C Viral recombinant vectors for expression in muscle cells |
| 07/19/2007 | WO2007081232A1 Drug combinations |
| 07/19/2007 | WO2007081060A1 Therapeutic agent for neuropathic pain |
| 07/19/2007 | WO2007081031A1 Glycosyltransferase inhibitor |
| 07/19/2007 | WO2007081030A1 Pyrrolopyridazinone compound |
| 07/19/2007 | WO2007080885A1 Cycloalkanecarboxamide derivative and method for producing same |
| 07/19/2007 | WO2007080882A1 Oxazolone derivative |
| 07/19/2007 | WO2007080847A1 Mutant growth factor with altered receptor specificity and pharmaceutical composition containing the same |
| 07/19/2007 | WO2007080669A1 Antiviral/antiinflammatory drug composition |
| 07/19/2007 | WO2007080378A1 Use of morpholino compounds for the treatment of halitosis |
| 07/19/2007 | WO2007064664A3 Prostaglandin ep4 agonists for the treatment of gastric conditions |
| 07/19/2007 | WO2007062462A8 Method for administering a skin necrosis composition to an animal |
| 07/19/2007 | US20070167611 Peptides and Peptidomimetics with Structural Similarity to Human p53 that Activate p53 Function |
| 07/19/2007 | US20070167511 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 07/19/2007 | US20070167501 Bicyclo derivative |
| 07/19/2007 | US20070167500 Remedy for urinary tract diseases |
| 07/19/2007 | US20070167498 Carboxylic acid compounds |
| 07/19/2007 | US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof |
| 07/19/2007 | US20070167483 Phenylalanine Enamide Derivatives |
| 07/19/2007 | US20070167481 Imidazonaphthyridines |
| 07/19/2007 | US20070167461 USE OF SUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO[1,2-a] PYRIMIDIN-5(1H)ONE DERIVATIVES AS THERAPEUTIC AGENTS |
| 07/19/2007 | US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 07/19/2007 | US20070167448 Derivatives of sulphonamides, their preparation and use as medicaments |
| 07/19/2007 | US20070167429 such as 2Z)-N-(2-hydroxyethyl)-2-{4,4,7-trifluoro-1-[4-{[(2S)-2-fluoropropyl]oxy}-2-(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene}acetamide, for treating or preventing urinary incontinence and/or diabetes |
| 07/19/2007 | US20070167425 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 07/19/2007 | US20070167377 Inhibitors of glycinamide ribonucleotide transformylase |
| 07/19/2007 | US20070167373 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 07/19/2007 | US20070167372 Ocular tear growth factor-like protein |
| 07/19/2007 | US20070167371 Treating deficient tear output and enhancing the proliferation of human corneal epithelial cells by contacting the ocular surface or the cells with a lacrimal gland protein that has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070166824 Manipulation of non-terminally differentiated cells using the notch pathway |
| 07/19/2007 | US20070166753 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy |
| 07/19/2007 | US20070166312 Antibody against tumor specific antigen as target |
| 07/19/2007 | US20070166280 Chemokines as adjuvants of immune response |
| 07/19/2007 | CA2637388A1 Pyrrolopyridazinone compound |
| 07/19/2007 | CA2636941A1 Drug combinations |
| 07/19/2007 | CA2636625A1 Oxazolone derivative |
| 07/19/2007 | CA2635787A1 Cycloalkanecarboxamide derivative and method for producing same |
| 07/18/2007 | EP1808446A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 07/18/2007 | EP1808184A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 07/18/2007 | EP1808176A2 5 alpha reduced glucocorticoid metabolites for the treatment of inflammation |
| 07/18/2007 | EP1808170A1 Aqueous eye drops with accelerated intraocular migration |
| 07/18/2007 | EP1808161A1 Microprojectile delivery system and particulate product |
| 07/18/2007 | EP1807118A2 Steroid analogs and characterization and treatment methods |
| 07/18/2007 | EP1525204B1 Phenylalanine enamide derivatives |
| 07/18/2007 | EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 07/18/2007 | EP1508566B1 (2s)-2-ethylphenylpropionic acid derivative |
| 07/18/2007 | EP1497436B1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolic disorders using such raav virons |
| 07/18/2007 | EP1458711B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
| 07/18/2007 | EP1453514B1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
| 07/18/2007 | EP1403251B1 Bis(2-aryl-5-pyridyl) derivative |
| 07/18/2007 | EP1403250B1 Bis(5-aryl-2-pyridyl) derivative |
| 07/18/2007 | EP1377280B1 Use of bulking agents as satiety agents |
| 07/18/2007 | EP1313707B1 Quinoline derivatives as anti-inflammation agents |
| 07/18/2007 | EP1306367B1 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 07/18/2007 | EP1249237B1 Topical cosmetic and pharmaceutical composition comprising specific alkoxylated diester of fumaric acid |
| 07/18/2007 | EP1226826B1 Remedies |
| 07/18/2007 | EP1150678B1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/18/2007 | EP1139753B1 Formulations for treating disease and methods of using same |
| 07/18/2007 | EP1054885B1 Benzisoxazole derivatives having d4-antagonistic activity |
| 07/18/2007 | EP1007044B1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
| 07/18/2007 | CN1326880C G-CSF receptor agonist antibodies and screening method therefor |
| 07/18/2007 | CN1326879C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/18/2007 | CN1326876C Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/18/2007 | CN1326859C Thienopyridine derivatives and their preparing process and use |
| 07/18/2007 | CN1326858C Novel tricyclic spiropiperidines or spiropyrrolidines |
| 07/18/2007 | CN1326855C Ring fused pyrazole derivatives |
| 07/18/2007 | CN1326853C Novel 4-2-furoylaminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 07/18/2007 | CN1326852C Benzofuran derivative |
| 07/18/2007 | CN1326850C Tricyclic farnesyl protein transferase inhibitors |
| 07/18/2007 | CN1326848C Aminopyrazole derivatives |
| 07/18/2007 | CN1326847C Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 07/18/2007 | CN1326841C Arylalkane-sulfonamides having endothelin-antagonist activity |
| 07/18/2007 | CN1326577C N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/18/2007 | CN1326569C Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative |
| 07/18/2007 | CN1326564C Aqueous immunologic adjuvant compositions of monophosphoryl lipid A |
| 07/18/2007 | CN1326562C Use of IL-18 inhibitors for treatment and/or prevention of heart disease |
| 07/18/2007 | CN1326560C Use of POLY-GLU,TYR treated therewith for neuroprotective therapy |
| 07/18/2007 | CN1326529C Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma |
| 07/18/2007 | CN1326523C Atineoplastic combinations |
| 07/18/2007 | CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 07/18/2007 | CN101001629A Medicinal composition |
| 07/18/2007 | CN100998851A Chinese medicinal preparation for curriculum of physical and fatigue reducing |
| 07/18/2007 | CN100998837A Black adhesive plaster for removing obstruction and relieving pain |
| 07/18/2007 | CN100998818A Oral Chinese medicine for treating damp-heat impairment of yang night sweating |